Skip to content

Clinical trials

Phase 1 Endocrine System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Phase: Phase 1 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20053
20061
20071
20082
20092
20101
20111
20132
20152
20191
20201
20211
20222
20231
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Withdrawn3
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Pittsburgh5
CRISPR Therapeutics AG2
Goldfinch Bio, Inc.2
Merck Sharp & Dohme LLC2
University Hospital, Basel, Switzerland2
Beta-Stim Ltd.1
Biohaven Therapeutics Ltd.1
Black Tie Medical, Inc.1
Corbus Pharmaceuticals Inc.1
Corcept Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases25
Metabolic Diseases11
Diabetes Mellitus10
Glucose Metabolism Disorders9
Diabetes Mellitus, Type 27
Musculoskeletal Diseases5
Osteoporosis5
Autoimmune Diseases3
Hyperparathyroidism3
Adrenal Gland Diseases2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.